Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma
Year: 2016
Type: article
Study design: Observational Study
Source: Clinical Cancer Research
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: diffuse large B-cell lymphoma, total metabolic tumor volume, FDG PET/CT, prognostic risk classification, germinal center B-cell subtype, activated B-cell subtype, MYC overexpression, Bcl-2 overexpression, progression-free survival, overall survival, rituximab, CHOP chemotherapy, SUVmax threshold
Open Access status: closed
OpenAlex ID: W2291210741
